Impax Laboratories

Hayward, United States Founded: 1999 • Age: 27 yrs Listed
Generic versions of brand-name medications are developed and manufactured.

About Impax Laboratories

Impax Laboratories is a publicly listed company based in Hayward (United States) founded in 1999. Generic versions of brand-name medications are developed and manufactured. The company has 148 employees. Impax Laboratories has completed 2 acquisitions, including CorePharma and Lineage Therapeutics. Its chief executive, as recorded, is Paul M. Bisaro. Impax Laboratories offers products and services including Generic Pharmaceuticals and Medical Information Services. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is Amneal Pharmaceuticals, Inc.

Company details

Impax Laboratories was founded in 1999 in Hayward, United States. Generic pharmaceutical products are produced by the company, including the development of equivalents to brand-name drugs. Operations span the pharmaceutical sector, covering research, manufacturing, and distribution processes. Quality control standards are enforced across production to support product safety and efficacy. The entity is headquartered in the United States, with activities centered on generic medication supply.

  • Headquarters Hayward, United States
  • Employees 148
  • Stage Public
  • Sectors
    Healthcare
  • Website impaxlabs.com
  • Social LinkedIn
  • Legal Name Amneal Pharmaceuticals, Inc
Key Metrics
  • Employee Count
    148
  • Investments & Acquisitions
    CorePharma

    & 1 more

Products & Services of Impax Laboratories

Impax Laboratories offers a comprehensive portfolio of products and services, including Generic Pharmaceuticals and Medical Information Services.

Generic Pharmaceuticals
Healthcare Products

Generic drugs are manufactured and distributed for medical purposes

Medical Information Services
Support Services

Services for reporting adverse events and product complaints are provided to ensure quality and safety

People of Impax Laboratories

10 people are tracked at Impax Laboratories (7 in leadership, 3 in team); the tracked headcount is 148.

NameRoleGroup
Paul M. Bisaro
CEOLeadership
Paul Bisaro
CEOLeadership
Michael Yoon
Associate Director Of Human ResourcesLeadership
Michael Nestor
PresidentLeadership
George Hill
VP FinanceLeadership
Annette Surtees
HR DirectorLeadership
Tiffany Nguyen
Director, Clinical OperationsLeadership
Samuel Adams
Senior Manager ProcurementTeam
Mark Wojtko
Senior AccountantTeam
John Perez
Regional Business ManagerTeam
Premium access

Complete people profiles for Impax Laboratories

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Impax Laboratories

Impax Laboratories has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CorePharma and Lineage Therapeutics.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Generic dosage forms for pharmaceuticals are manufactured by Lineage Therapeutics.
lineagetherapeutics.comHorsham, United States2015Mar 2015β€’β€’β€’β€’
Generic pharmaceuticals are developed, manufactured, and sold by CorePharma.
corepharma.comMiddlesex, United States1998Mar 2015β€’β€’β€’β€’
Premium access

Complete acquisition details for Impax Laboratories

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Impax Laboratories

4 dated milestones of Impax Laboratories across 16 years, from founding to its latest funding, stage changes and deals.

  1. Founded Impax Laboratories is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Lineage Therapeutics.
  4. Acquisition Acquires CorePharma.

Web traffic of Impax Laboratories

Websites that share an audience with Impax Laboratories (impaxlabs.com).

Similar websites

Websites whose visitors overlap most with Impax Laboratories. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
akorn.com
100%
#11,843,991View details
amgen.com
96%
495.4K#116,434View details
endo.com
96%
10K#2,323,439View details
tevapharm.com
95%
166.9K#278,209View details
roche.com
90%
1.3M#42,219View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 31 similar websites and full traffic analytics for Impax Laboratories

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 31 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Impax Laboratories (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United StatesUSD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United StatesUSD 5.1 B13,500
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Impax Laboratories

Impax Laboratories was founded in 1999.

Impax Laboratories is headquartered in Hayward, United States. It is registered at Hayward, California, United States.

Paul M. Bisaro is the CEO of Impax Laboratories, as recorded in our data.

Impax Laboratories has 148 employees.

Impax Laboratories was founded in 1999 in Hayward, United States. Generic pharmaceutical products are produced by the company, including the development of equivalents to brand-name drugs. Operations span the pharmaceutical sector, covering research, manufacturing, and distribution processes. Quality control standards are enforced across production to support product safety and efficacy. The entity is headquartered in the United States, with activities centered on generic medication supply.

Impax Laboratories offers Generic Pharmaceuticals and Medical Information Services.

Impax Laboratories has made 2 acquisitions, including CorePharma, and Lineage Therapeutics.

Impax Laboratories operates through Amneal Pharmaceuticals, Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available